Routine Asthma Test More Reliable in the Morning and Has Seasonal Effects, Say Doctors Mar. 12, 2025 — A lung function test used to help diagnose asthma works better in the morning, becoming ...

Asthma is the most common chronic disease of childhood and, in the latter part of the 20th century, reached epidemic proportions. Asthma is generally believed to result from gene-environment ...

Teva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to a phone to help manage asthma and ... or prevention of bronchospasm who have ...

Pope Francis had been suffering from health issues in the weeks before his death, including a more than one-month stay in the ...

Roshni Naik, MD, allergist at Mount Sinai Health System, discusses the history of present illness for a case of severe asthma with nasal polyps: "Patient is a 45 year-old male with a past medical ...

The following is a summary of “Association of eosinophil-to-monocyte ratio with asthma exacerbations in adults: a cross-sectional analysis of NHANES data,” published in the April 2025 issue of the BMC ...

Experts from the University of Manchester have found that if a person with asthma takes their brown inhaler between 3pm and 4pm, they may see symptoms improve. The research, published in the ...

The first-in class medicine for severe asthma co-developed by AstraZeneca and Amgen is poised for accelerated approval after the US Food and Drug Administration granted it a breakthrough designation.

The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain symptomatic despite histamine-1 antihistamine treatment, according to a ...

For millions of people around the world, asthma is a constant struggle. It’s not just about wheezing or coughing—it’s a chronic condition where the immune system overreacts to harmless ...

Although bronchial hyperresponsiveness to cholinergic agents is a main feature of asthma, the role of anticholinergic drugs in chronic asthma management has been largely underestimated.